Skip to main content
Top
Published in: Infection 3/2016

01-06-2016 | Case Report

Necrotizing fasciitis due to Serratia marcescens: case report and review of the literature

Authors: Rohit Majumdar, Nancy F. Crum-Cianflone

Published in: Infection | Issue 3/2016

Login to get access

Abstract

Background

Necrotizing fasciitis is a severe, life-threatening infection.  Serratia marcescens, a Gram-negative bacterium, is an extremely rare cause of necrotizing fasciitis.

Methods

A case of S. marcescens necrotizing fasciitis is described, and a comprehensive review of the literature (1966-2015) of monomicrobial cases due to this organism performed.

Results

We report the first case of S. marcescens necrotizing fasciitis in the setting of calciphylaxis associated with end-stage renal disease.  A comprehensive review of the literature of S. marcescens necrotizing fasciitis is provided to enhance the awareness of this increasingly recognized infection, and to provide a concise summary of risk factors, treatment, and outcome.

Conclusions

Our case and review highlight the potential risk factors for S. marcescens necrotizing fasciitis, including underlying renal disease and open wounds, and demonstrate the emergence of this organism as a cause of severe, life-threatening soft tissue infections.
Literature
1.
go back to reference Tu GW, Hwabejire JO, Ju MJ, Yang YF, Zhang GJ, Xu JW, Xue ZG, Jiang C, Luo Z. Multidisciplinary intensive care in extensive necrotizing fasciitis. Infection. 2013;41:583–7.CrossRefPubMed Tu GW, Hwabejire JO, Ju MJ, Yang YF, Zhang GJ, Xu JW, Xue ZG, Jiang C, Luo Z. Multidisciplinary intensive care in extensive necrotizing fasciitis. Infection. 2013;41:583–7.CrossRefPubMed
2.
go back to reference Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33:2382–7.PubMedPubMedCentral Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33:2382–7.PubMedPubMedCentral
3.
go back to reference Ivády B, Szabó D, Damjanova I, Pataki M, Szabó M, Kenesei É. Recurrent outbreaks of Serratia marcescens among neonates and infants at a pediatric department: an outbreak analysis. Infection. 2014;42:891–8.CrossRefPubMed Ivády B, Szabó D, Damjanova I, Pataki M, Szabó M, Kenesei É. Recurrent outbreaks of Serratia marcescens among neonates and infants at a pediatric department: an outbreak analysis. Infection. 2014;42:891–8.CrossRefPubMed
4.
go back to reference Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med. 1979;300:887–93.CrossRefPubMed Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med. 1979;300:887–93.CrossRefPubMed
5.
go back to reference Aucken HM, Pitt TL. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. J Med Microbiol. 1998;47:1105–13.CrossRefPubMed Aucken HM, Pitt TL. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. J Med Microbiol. 1998;47:1105–13.CrossRefPubMed
6.
go back to reference Conroy MC, Bander NH, Lepow IH. Effects in the rat of intradermal injection of purified proteinases from streptococcus and Serratia marcescens. Proc Soc Exp Biol Med. 1975;150:801–6.CrossRefPubMed Conroy MC, Bander NH, Lepow IH. Effects in the rat of intradermal injection of purified proteinases from streptococcus and Serratia marcescens. Proc Soc Exp Biol Med. 1975;150:801–6.CrossRefPubMed
7.
go back to reference Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis. 1987;155:143–6.CrossRefPubMed Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis. 1987;155:143–6.CrossRefPubMed
8.
go back to reference Bornstein PF, Ditto AM, Noskin GA. Serratia marcescens cellulitis in a patient on hemodialysis. Am J Nephrol. 1992;12:374–6.CrossRefPubMed Bornstein PF, Ditto AM, Noskin GA. Serratia marcescens cellulitis in a patient on hemodialysis. Am J Nephrol. 1992;12:374–6.CrossRefPubMed
9.
go back to reference Zipper RP, Bustamante MA, Khatib R. Serratia marcescens: a single pathogen in necrotizing fasciitis. Clin Infect Dis. 1996;23:648–9.CrossRefPubMed Zipper RP, Bustamante MA, Khatib R. Serratia marcescens: a single pathogen in necrotizing fasciitis. Clin Infect Dis. 1996;23:648–9.CrossRefPubMed
10.
go back to reference Huang JW, Fang CT, Hung KY, Hsueh PR, Chang SC, Tsai TJ. Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy. J Formos Med Assoc. 1999;98:851–4.PubMed Huang JW, Fang CT, Hung KY, Hsueh PR, Chang SC, Tsai TJ. Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy. J Formos Med Assoc. 1999;98:851–4.PubMed
11.
go back to reference Liangpunsakul S, Pursell K. Community-acquired necrotizing fasciitis caused by Serratia marcescens: case report and review. Eur J Clin Microbiol Infect Dis. 2001;20:509–10.CrossRefPubMed Liangpunsakul S, Pursell K. Community-acquired necrotizing fasciitis caused by Serratia marcescens: case report and review. Eur J Clin Microbiol Infect Dis. 2001;20:509–10.CrossRefPubMed
12.
go back to reference Bachmeyer C, Sanguina M, Turc Y, Reynaert G, Blum L. Necrotizing fasciitis due to Serratia marcescens. Clin Exp Dermatol. 2004;29:673–4.CrossRefPubMed Bachmeyer C, Sanguina M, Turc Y, Reynaert G, Blum L. Necrotizing fasciitis due to Serratia marcescens. Clin Exp Dermatol. 2004;29:673–4.CrossRefPubMed
13.
go back to reference Curtis CE, Chock S, Henderson T, Holman MJ. A fatal case of necrotizing fasciitis caused by Serratia marcescens. Am Surg. 2005;71:228–30.PubMed Curtis CE, Chock S, Henderson T, Holman MJ. A fatal case of necrotizing fasciitis caused by Serratia marcescens. Am Surg. 2005;71:228–30.PubMed
14.
go back to reference Statham MM, Vohra A, Mehta DK, Baker T, Sarlay R, Rutter MJ. Serratia marcescens causing cervical necrotizing oropharyngitis. Int J Pediatr Otorhinolaryngol. 2009;73:467–73.CrossRefPubMed Statham MM, Vohra A, Mehta DK, Baker T, Sarlay R, Rutter MJ. Serratia marcescens causing cervical necrotizing oropharyngitis. Int J Pediatr Otorhinolaryngol. 2009;73:467–73.CrossRefPubMed
15.
go back to reference Prelog T, Jereb M, Cuček I, Jazbec J. Necrotizing fasciitis caused by Serratia marcescens after venous access port implantation in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34:e246–8.CrossRefPubMed Prelog T, Jereb M, Cuček I, Jazbec J. Necrotizing fasciitis caused by Serratia marcescens after venous access port implantation in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34:e246–8.CrossRefPubMed
16.
go back to reference Wen YK. Necrotizing fasciitis caused by Serratia marcescens: a fatal complication of nephrotic syndrome. Ren Fail. 2012;34:649–52.CrossRefPubMed Wen YK. Necrotizing fasciitis caused by Serratia marcescens: a fatal complication of nephrotic syndrome. Ren Fail. 2012;34:649–52.CrossRefPubMed
17.
18.
go back to reference Cope TE, Cope W, Beaumont DM. A case of necrotising fasciitis caused by Serratia marsescens: extreme age as functional immunosuppression? Age Ageing. 2013;42:266–8.CrossRefPubMed Cope TE, Cope W, Beaumont DM. A case of necrotising fasciitis caused by Serratia marsescens: extreme age as functional immunosuppression? Age Ageing. 2013;42:266–8.CrossRefPubMed
19.
go back to reference Vano-Galvan S, Álvarez-Twose I, Moreno-Martín P, Jaén P. Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host. Int J Dermatol. 2014;53:e57–8.CrossRefPubMed Vano-Galvan S, Álvarez-Twose I, Moreno-Martín P, Jaén P. Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host. Int J Dermatol. 2014;53:e57–8.CrossRefPubMed
20.
21.
go back to reference Zhao WH, Hu ZQ, Chen G, Ito R, Shimamura T. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations. Chemotherapy. 2008;54:31–7.CrossRefPubMed Zhao WH, Hu ZQ, Chen G, Ito R, Shimamura T. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations. Chemotherapy. 2008;54:31–7.CrossRefPubMed
22.
go back to reference Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–88.CrossRefPubMed Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–88.CrossRefPubMed
Metadata
Title
Necrotizing fasciitis due to Serratia marcescens: case report and review of the literature
Authors
Rohit Majumdar
Nancy F. Crum-Cianflone
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0855-x

Other articles of this Issue 3/2016

Infection 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.